CLOSTRIDIOIDES DIFFICILE INFECTION
Clinical trials for CLOSTRIDIOIDES DIFFICILE INFECTION explained in plain language.
Never miss a new study
Get alerted when new CLOSTRIDIOIDES DIFFICILE INFECTION trials appear
Sign up with your email to follow new studies for CLOSTRIDIOIDES DIFFICILE INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Poop pills vs. placebo: can gut bacteria tame colitis?
Disease control Recruiting nowThis study is testing whether transplanting healthy stool bacteria into people with ulcerative colitis can help control the disease. It involves 85 adults with active colitis who will receive either the transplant or a placebo. The goal is to see if this approach is worth testing…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1 • Sponsor: University of Alberta • Aim: Disease control
Last updated May 17, 2026 00:45 UTC
-
Poop pills vs antibiotics: new hope for gut infections?
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) after standard antibiotics works better than antibiotics alone for treating a first or first-return C. diff infection. About 220 adults with severe or non-severe C. diff will take either antibiotics followed by FMT caps…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: Benoit Guery • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Vancomycin shield may stop c. diff from coming back during antibiotic treatment
Disease control Recruiting nowThis study tests whether taking oral vancomycin can prevent a repeat Clostridioides difficile infection in people who recently had one and now need another antibiotic. About 300 adults will be randomly assigned to receive vancomycin or a placebo while on other antibiotics and for…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 26, 2026 19:38 UTC
-
New shot aims to stop c. diff's vicious cycle
Prevention Recruiting nowThis study tests an experimental drug called AZD5148 to see if it can prevent repeat Clostridioides difficile infections in adults aged 18 and older. About 230 participants will receive either the drug or a placebo. The main goal is to see if the drug reduces the chance of anothe…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Prevention
Last updated May 17, 2026 00:44 UTC
-
Could a 14-Day pill break the cycle of recurring c. diff?
Prevention Recruiting nowThis study tests an experimental treatment called VE303 to see if it can prevent repeat Clostridioides difficile (C. diff) infections. About 852 people who have had C. diff before will take either VE303 or a placebo for 14 days. The main goal is to check if fewer people get anoth…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Prevention
Last updated May 17, 2026 00:30 UTC
-
Could a single friendly gut bug prevent c. diff from coming back?
Prevention Recruiting nowThis study tests a new treatment called EXL01, which contains a single type of beneficial gut bacteria (Faecalibacterium prausnitzii), to see if it can prevent repeat Clostridioides difficile infections in people at high risk. About 56 adults who have had at least two or three C.…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE1, PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated May 14, 2026 12:05 UTC
-
New drug aims to break the cycle of recurring c. diff infections
Prevention Recruiting nowThis study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infections from returning after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more peo…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated May 11, 2026 20:41 UTC
-
C. diff treatment showdown: antibiotics vs. fecal transplants under the microscope
Knowledge-focused Recruiting nowThis study watches 200 adults with C. diff infection to see how standard antibiotics and fecal microbiota transplantation (FMT) work. Researchers will collect stool, blood, and tissue samples over up to 5 years to understand which treatment leads to better recovery and why. The g…
Matched conditions: CLOSTRIDIOIDES DIFFICILE INFECTION
Sponsor: Umeå University • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC